Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, announced positive topline results from an open-label, phase 2 congenital adrenal hyperplasia (CAH ... clinical safety ...
No consistent clinically important trends were observed across key safety parameters, including clinical safety laboratory values, physical examination ... is currently in development for congenital ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback